What it's for (Indications)
- This topical medication, combining hydrocortisone and gentamicin, is indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses where a secondary bacterial infection is present or suspected, or where there is a high risk of such an infection.
- Common conditions include eczema (e.
- g.
- , atopic dermatitis, contact dermatitis), psoriasis, seborrheic dermatitis, and other inflammatory dermatoses that have become secondarily infected with bacteria susceptible to gentamicin.
- The hydrocortisone component reduces inflammation, itching, and redness, while gentamicin, an aminoglycoside antibiotic, targets bacterial pathogens.
- It is crucial that the bacterial infection component is present or strongly suspected, as routine use of combination products without an infection is not recommended due to the risk of antibiotic resistance and potential for masking signs of infection.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | This medication is for external use only. A thin film of the cream or ointment should be applied gently to the affected skin area, typically two to three times daily, or as directed by a healthcare professional. The treatment duration should generally be limited to a maximum of 7 to 14 days, primarily to minimize the risk of developing corticosteroid-induced adverse effects, such as skin atrophy, and to prevent the emergence of antibiotic resistance. Prolonged use, application to large surface areas, or use under occlusive dressings should be approached with caution and under strict medical supervision, as these practices can significantly increase systemic absorption of both components, leading to potential adverse effects. Hands should be washed thoroughly before and after application, unless the hands are the area being treated. Avoid contact with eyes and mucous membranes. |
Safety & Warnings
Common Side Effects
- Topical application of hydrocortisone and gentamicin may lead to various local and, less commonly, systemic side effects.
- Local reactions commonly associated with the corticosteroid component include burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.
- The gentamicin component may cause local irritation, erythema, pruritus, and sensitization.
- Systemic absorption, though rare with appropriate topical use, can occur, especially with prolonged application, extensive surface area treatment, use on damaged skin, or under occlusive dressings.
- Systemic effects of corticosteroids may include suppression of the hypothalamic-pituitary-adrenal (HPA) axis, Cushing's syndrome, hyperglycemia, and glucosuria.
- Systemic absorption of gentamicin, though extremely rare from topical application to intact skin, theoretically carries risks of ototoxicity and nephrotoxicity, particularly in patients with pre-existing renal impairment or when applied to large areas of denuded skin.
Serious Warnings
- Black Box Warning: ### SERIOUS WARNINGS: POTENTIAL FOR SYSTEMIC EFFECTS AND ANTIMICROBIAL RESISTANCE While systemic absorption of topically applied hydrocortisone and gentamicin is generally low, significant risks can emerge with improper or prolonged use, necessitating careful patient monitoring and adherence to prescribed guidelines. **Corticosteroid-Induced Systemic Effects:** Prolonged application, use on large surface areas, application to damaged skin, or employment of occlusive dressings can lead to sufficient systemic absorption of hydrocortisone to cause reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria. Pediatric patients are particularly susceptible due to a larger skin surface area-to-body weight ratio. HPA axis suppression can lead to adrenal insufficiency upon abrupt withdrawal. Therefore, treatment duration should be limited, and patients monitored for signs of systemic absorption. **Antimicrobial Resistance and Superinfection:** The gentamicin component, an aminoglycoside antibiotic, carries the risk of promoting antimicrobial resistance with prolonged or unnecessary use. Indiscriminate use can foster the selection and proliferation of resistant bacterial strains, rendering future antibiotic treatments less effective. Furthermore, prolonged use may lead to the overgrowth of non-susceptible organisms, including fungi, potentially resulting in secondary infections requiring alternative therapeutic interventions. It is critical to limit the duration of treatment to the shortest necessary period to minimize these significant risks.
- This medication is intended for external use only and should not be used orally, ophthalmically, or intravaginally.
- Avoid contact with eyes, mucous membranes, and open wounds.
- Prolonged use, application to large body surface areas, or the use of occlusive dressings can significantly increase systemic absorption of hydrocortisone, leading to potential HPA axis suppression, Cushing's syndrome, hyperglycemia, and other systemic corticosteroid effects, particularly in pediatric patients who are more susceptible due to a larger skin surface area to body weight ratio.
- The gentamicin component, if absorbed systemically, carries risks of ototoxicity and nephrotoxicity, especially in patients with impaired renal function, although this is exceedingly rare with topical application.
- Use of topical antibiotics should be limited in duration to prevent the development of bacterial resistance and the overgrowth of non-susceptible organisms, including fungi.
- If irritation, sensitization, or superinfection occurs during treatment, discontinue the medication and initiate appropriate therapy.
- This product is not recommended for viral skin infections (e.
- g.
- , herpes simplex, varicella), fungal infections, tuberculosis of the skin, rosacea, or perioral dermatitis.
How it Works (Mechanism of Action)
The therapeutic efficacy of this combination product stems from the distinct pharmacological actions of its two active components. Hydrocortisone, a low-potency corticosteroid, exerts its anti-inflammatory, antipruritic, and vasoconstrictive effects primarily by inducing phospholipase A2 inhibitory proteins, collectively called lipocortins. These proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid, from membrane phospholipids. This action stabilizes cellular and lysosomal membranes, reduces capillary permeability, and inhibits the migration of neutrophils and macrophages to the site of inflammation. Gentamicin, an aminoglycoside antibiotic, functions by inhibiting bacterial protein synthesis. It achieves this by irreversibly binding to the 30S ribosomal subunit of susceptible bacteria, leading to the misreading of messenger RNA (mRNA) and the production of non-functional proteins, ultimately resulting in bacterial cell death. It exhibits a broad spectrum of activity against many Gram-negative and some Gram-positive bacteria.